Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine dose-ranging study on propofol requirements during propofol-remifentanil general anesthesia
ChiCTR-TRC-12002180Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ketamine, propofol and remifentanil in None (5 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Dosage of propofol. Started May 2012; status: completed.
02
Drugs
ketaminepropofolremifentanil
Beyond the preview
Go deeper on ChiCTR-TRC-12002180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002180.